Biomotion

2023
Manufacturing & circular economy
Austria

Description

Biomotion is a producer of 3D bioprinting systems, allowing the additive manufacturing of human tissue products for use in personalised medicine, tissue engineering products and for drug testing purposes. Their customers are mainly biopharmaceutical companies that aim to commercialize such tissue products. With their bioprinting systems, they enable they customers to fabricate tissue products in a reproducible and automated way, ensuring that their reject rate is kept at a minimum and they can reliably manufacture within the regulatory framework.

 

Industry domain

Additive Manufacturing

Biofabrication

Tissue Engineering

Investment stage and needs

The company is in the pre-seed stage with first customers and first products delivered in Europe.

Pitch deck

The X2.0 Acceleration Program

Team

Gregor Weisgrab
CEO
Diego Castaneda-Garay
CEO

Would you like to be an Impact Builder?